ARTICLE | Clinical News

BAY 81-8973 regulatory update

January 5, 2015 8:00 AM UTC

Last month, Bayer submitted a BLA to FDA and an MAA to EMA for BAY 81-8973 to treat hemophilia A in children and adults. The product is a plasma protein-free version of Bayer’s Kogenate FS, a recombi...